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Abstract 
Pharmacoeconomics is the set of methods applied to the eco-
nomic evaluation of pharmacological treatments. Its goal is to
determine the best possible health outcome with the available
resources by comparing costs (inputs) and the consequences/bene-
fits (outcomes) of one or more alternative choices. Ozone therapy
can be considered as a powerful alternative to traditional methods
in the management and treatment of several diseases, like, e.g.
rheumatoid arthritis, lumbago, disc hernia, knee and hip disease,
fibromyalgia, stroke outcomes, neurodegenerative syndromes and
more. It is thus a very interesting topic to compare the costs and
outcomes of ozone based treatments with those coming from other
alternative methods, with the perspective of pharmacoeconomics.
Several methods have been proposed for pharmacoeconomical
analysis, including statistical and simulation tools. The purpose of
this research paper is to review some of the simulation tools that
could be used in this field and in particular to propose a hybrid sim-
ulation method, defined as agent based process simulation, which
considers not only the involved costs, but also other non-monetary
outcomes. In the same vein, a data mining set of techniques is pro-
posed to collect data and to feed the simulation model.
Introduction
Pharmacoeconomics1 is the set of methods applied to the eco-
nomic evaluation of pharmacological treatments. It may be
defined as a tool that allows choices to be made using explicit and
rational criteria. According to the traditional approach, the evalu-
ation of a pharmacological therapy is made in the light of three
clinical indicators: tolerability (safety), clinical efficacy (efficacy),
and epidemiological efficacy. The first checks for the presence or
absence of side effects related to the administration of treatment,
the second determines whether the condition of patients’ treatment
improve in function of the therapy administered, and the third
checks whether the treatment can be used advantageously in gen-
eral medical practice. The economic approach, i.e. pharmacoeco-
nomic evaluation, adds to the three indicators of the traditional
approach the principle of allocative efficiency, thus shifting the
analysis also on the cost side with the aim of determining the best
possible health outcome with resources (scarce) available. It
should be remembered that allocative efficiency means the con-
venience in allocating scarce resources between possible alterna-
tive uses (therapeutic treatments).
The goal of pharmacoeconomy1 is therefore to determine the
best possible health outcome with the available resources by com-
paring costs (inputs) and the consequences/benefits (outcomes) of
one or more alternative choices. Components of the economic
evaluation are therefore costs (input) and consequences or benefits
(outcomes). Costs are generally divided into direct, indirect and
intangible and are always expressed in monetary units. The bene-
fits may also be directly expressed in monetary units, or may be
indicators of intermediate or final result and therefore expressed,
e.g. as arterial pressure, lives saved, cases diagnosed, cases avoid-
ed, Life Years, Quality Adjusted Life Years, and so on.
Ozone therapy is one of the modern non-drug treatment meth-
ods. It has been used for more than 100 years. Medical reports on
the successful use of ozone in the treatment of various diseases
and studies on its effects have led to a rapidly growing interest in
it. Some other factors were responsible for the wide spread, such
as the simplicity of performance, the good tolerability by the
patients, the absence of side effects or side effects and the high
medical-social and economic efficiency. In this specific field, it is
of great interest to compare the outcomes and costs of a traditional
therapy with those of a therapy based on ozone.
In such a complex scenario, where it would be useful to eval-
uate not only the economical difference among treatments, but
also social and health factors have to be taken into account, a very
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interesting tool to use would be simulation. While there exist many
simulation paradigms, two of them seem optimal for this task: dis-
crete event process simulation (for its capability of reproducing a
well-known situation with process based blocks) and agent based
simulation (for the possibility of building models with a bottom-up
approach, by defining the interaction rules and letting the aggre-
gate behaviour to emerge in a spontaneous way. The combination
of the two is proposed in this paper, with the aid of a data mining
technique, in two different perspectives: ex ante, to help collecting
data to be used in the simulation model; ex post, to help analysing
and selecting data coming from the simulation.
Pharmacoeconomics: the scenario
The economic assessment of a treatment is undertaken for two
fundamental reasons. The first is that the objectives of public insti-
tutions, including the health of citizens, may not be measurable
directly by optimising the profit of some producers, but require the
composition of interests, sometimes conflicting, in order to
achieve the highest possible collective welfare. The second is the
presence of numerous distortions and imperfections that affect the
prices of both inputs and goods in the health market, both private
and public (so-called market failures).
This is because the pharmaceutical sector is moving away from
a competitive market, so much so that it can be defined as a non-
market, in fact the presence of an uninformed consumer, i.e. who
is not able to make choices that express her preferences and who,
in any case, does not have of the necessary information on the effi-
cacy/safety of the pharmacological alternatives on the market, the
function of the doctor who decides for the patient and social
demand shifting the burden from the consumer to a paying third
party allows the producer to raise the price above the break-even
point and the consumer to demand more expensive quantities of
goods and services than would be the case in a context of perfect
competition. So, since resources are scarce by definition, it is not
sufficient for a drug to be effective to justify its administration, the
costs should also be estimated economics that it induces in order to
be able to choose between different alternative uses of the
resources themselves. Pharmacoeconomics1 is therefore the set of
methods applied the economic evaluation of pharmacological
treatments, can therefore rightly be defined as interaction between
clinical and economic evaluation.
As to the involved costs, pharmacoeconomic classifies costs
differently according to their nature. The costs can be divided into
three main categories: direct costs (health and non-health), indirect
costs (health and non-health), and intangible costs. Direct costs are
associated with the resources used by the programme. They are
divided into direct health costs and direct non-health costs. Direct
health costs include all costs incurred by the National Health
Service and third party payers (e.g. private insurance); they are
represented by resources used in prevention, diagnosis, and thera-
py and rehabilitation (e.g. drugs, medical materials, examinations
laboratory equipment, hospitalisation, etc.). Direct non-health
costs are those costs related to the resources of non-health nature
consumed as a result of the programme. Usually these are the ones
supported by the patient (such as transport costs and the costs of
access to social assistance services). Indirect non-health costs rep-
resent the value of resources that are not produced by the disease,
either by the patient or by other (family members), as the latter do
not provide professional care; they therefore represent the reduced
or lost productivity of patients and their families. The classic
example is days off work and/or loss or loss of working ability.
Indirect health costs are the costs that will have to be borne in the
future due to the increased survival (life expectancy) of the patient
as a result of the treatment programme. Finally, intangible costs
describe the costs associated with the physical and psychological
distress associated with the morbid condition. Often these costs,
due to obvious problems of valorisation, are not quantified in mon-
etary terms, but converted into measurements of the reduced qual-
ity of life of patients.
An important step in the evaluation of costs in pharmacoeco-
nomics is the process of attributing the appropriate unit cost for
each resource considered in the analysis. For all those resources
(e.g. drugs and medicines) whose cost corresponds to a purchase
price on the market, the operation of valorisation is rather simple,
while for the other resources, which do not have a specific refer-
ence in the market, different considerations apply. An alternative
method, which helps in the absence of market prices, is to use the
Fares (if available). For example, the Diagnosis Related Group
reimbursement rates are available for hospitalisation, while for the
vast majority of other medical/ambulatory services there is a rate
(National or Regional). However, it should be noted that the use of
tariffs creates problems; in fact, tariffs rarely coincide with the real
cost of the services to which they refer, since they can usually be
values determined by an agreement between the supplier and the
lender, or estimates of values on a sample basis, or adjustments to
historical values previously agreed. The so-called human capital
method is a reference method for estimating indirect costs, which
are considered as total loss of production. On the basis of this
approach, in the case of impossibility to work due to sickness, the
loss of production may be calculated using an estimate of the aver-
age daily gross income of the worker absent due to sickness.
Ozone therapy: a brief review of main positive effects
for the medical field
Medical reports on the successful use of ozone in the treatment
of various diseases and studies on its effects have led to a rapidly
growing interest in it. Even if the purpose of this paper is not
analysing the effectiveness of ozone, it’s worth mentioning that
ozone has proved to have several positive effects and interactions
that could be employed in the medical filed. Here follows a non-
exhaustive list.2
Effects on metabolism
Increase in glycolysis delta: the high amount of energy
released from the aerobic demolition of glucose is used for the syn-
thesis of ATP, but it is clear that the efficiency of the process
depends on the continuous supply of oxygen. There are circum-
stances in which the demand for ATP by different organs increases.
In these cases, the sudden increase in ATP demand can only be par-
tially met by an increase in the speed of mitochondrial oxidative
processes and the oxygen supply remains insufficient to meet
demand. Under these conditions, glycolysis, which can meet the
demand for ATP to ensure the energy requirements necessary to
maintain cellular homeostasis and the required performance. This
makes it clear that the acceleration of glycolysis since ozone, fol-
lowing its action on coenzymes, leads to increased ATP formation.
Activation of Lipid metabolism: this effect ascribable to ozone
is aura- towards an intervention on fat catabolism and for a direct
lipolytic effect. All this has the consequence of an increased pro-
duction of energy that is useful in all these conditions, especially
physiological, where an increase in work is required.
Effects on red blood cells and microcirculation
The erythrocyte membrane is composed structurally of pro-
teins, carbon hydrates and phospholipids. The first phase of the
reaction is represented by the reaction of ozone with the double
bonds of unsaturated fatty acids of the membrane of erythrocytes
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(electrophilic addition), so short chain peroxides penetrate into the
erythrocytes themselves, influencing their metabolism. This means
more sugar being broken up and the most important product of this
reaction chain is diphosphoglycerate, which, as a deoxygenating
substance, is the key element in the therapeutic effect of ozone by
moving the haemoglobin dissociation curve to the right. On the
other hand, the formation of peroxides would lead to an increase in
hydrogen ions in the hell of red blood cells, since the oxygenated
hemoglobin behaves like a stronger acid than the deoxygenated
hemoglobin, this change in pH by varying the affinity of Hb for
oxygen would lead to a greater transfer of the same (Bohr effect).
Action on rheology
The administration of ozone induces, at low concentrations, a
reduction in the overall blood viscosity and platelet aggregation.
These erythrocyte modifications are testified by an increase in the
erythrocyte filterability in the smaller capillaries, where the emazie
instead of moving disorderly align and proceed along the axis of
the vase by placing themselves in a stack (Fahraeus-Lindquist
effect), increase the deformability thus facilitating metabolic
exchanges.
Bactericidal fungicidal and virus static action
The bactericidal and fungicidal action derives from the direct
contact between the ozone and the microorganisms and is due to
the destruction of the capsule subjected to the oxidative process
determined by the gas and/or peroxides. The virus action of ozone
and its peroxides is carried out instead by the cellular receptors
present on the viral surface in such a way as to prevent contact
between vims and the target cell, so that the entire replication cycle
is stopped. In fact, the penetration of cell vims is possible because
the acceptors of vims are made up of N-acetylglucosamine while
the cellular receptors are made up of N-acetylneuraminicol.
Action on the immune system
It has been observed that oxidising agents such as hydrogen per-
oxide can stimulate the activation of lymphocytes or monocytes
causing the release of cytokines including: interferons, tumour
necrosis factor and interleukins. It was concluded that this gas is
capable both in vitro and in vivo of determining a blood-verifiable
immunomodulating effect with the gradual reduction of serum
immunoglobulins and the rapid fall in the clearance of circulating
immune complexes. Laboratory data allow to highlight an inductive
role by the O3 on the production of different cytokines. All this opens
a wide field of research on the possible therapeutic developments of
O2O3 in the treatment of different diseases of immune origin.
Analgesic and anti-inflammatory action
Therapy with ozone leads to a rapid disappearance of joint pain
and oedema and a normalisation of local temperature, with
increased mobility and articular function. These effects are proba-
bly due to the inhibition of proinflammatory prostaglandin synthe-
sis or the release of bradykinin or halogen compounds; neutralisa-
tion of reactive oxygen species by stimulating local production of
antioxidant enzymes; inhibition of the release of proteinase from
macrophages and neutrophil polymorphonucleates; modulation of
the production of proinflammatory cytokines. The effect of ozone
on the components of the intravertebral disc is complex and very
excused. It is believed that ozone has positive effects on both the
protein component and on the glycemic one and on the water con-
tained in the po1poso6 nucleus. In particular, an activation of the
local metabolism could be realized to increase local oxygenation
and a direct effect on the altered components of the hemiatol inter-
vertebral disc. This would explain the reason for the positive
results after ozone therapy in treating chronic situations very dif-
ferent from each other in terms of pathological constitution and
localization6 In addition, different diseases related to the muscu-
loskeletal system can benefit both when it comes to inflammatory
and degenerative events. This in relation to a series of linked
effects that, starting from an improvement of the local micro vas-
cularisation, could cause the removal of algogenic substances with
relative tissue disinflammation, reduction of contracture and oede-
ma, recovery of rachis mobility and therefore the arrest of the
pathophysiological mechanisms of degeneration.
Uses in treatments for several diseases
Considering all this, ozone has been and is used successfully to
treat several diseases. Some of those are: hepatitis C acute and
chronic liver disease, chronic liver disease (hepatitis C and B) cir-
rhosis, hypercholesterolemia, lymphedema, colibacillosis, eczema
anal hemorrhoids, proctitis, constipation, ulcerative colitis (Crohn
disease), gastritis, gastric and duodenal ulcer, herniated disc, con-
flicts discorradiculares, arthritis, rheumatic, periarthritis,
fibromyalgia, chronic fatigue syndrome, multiple sclerosis, carpal
tunnel, backache, back pain, sciatic pain, osteoarthritis,
osteomyelitis, vertebral osteochondrosis, gonarthrosis, spondy-
larthritis, ankylosing spondylitis, synovitis, tendonitis, bursitis,
trochanters, hip osteoarthritis, epicondylitis (tennis elbow), pubal-
gia, ischial bursitis, post-surgical fibrosis, etc., migraine, trigemi-
nal neuralgia, post-herpetic neuralgia, circulatory headache, clus-
ter headache, Parkinson’s disease, depression, phlebology and
angiology, venous insufficiency, diabetic ulcer, diabetic foot, decu-
bitus sores (bed sores), varicose veins, spider veins, degenerative
vascular diseases (arteriosclerosis obliterans), lymphangitis, furun-
culosis, recent thrombophlebitis, pathologies flebiáticas, gangrene,
etc., ischemic heart disease, cardiac stenosis, angina pectoris,
venous hypertension syndrome, hypertension, etc., adjuvant radio-
therapy and chemotherapy in cancer, helping in the acquired
immunodeficiency syndrome (AIDS), senile dementia,
Alzheimer’s, arteriosclerosis, cerebral sclerosis and Parkinson’s,
open-angle glaucoma, optic neuropathy, retinitis pigmentosa and
AMD, gingivitis, alveolitis, cloceovestibular syndrome, chronic
tonsillitis, pharyngitis infectious, peripheral vestibulocochlear syn-
drome, Chronic pelvic inflammation, recurrent vulvovaginitis,
genito-urinary infections by viruses, fungi / bacteria, mastodinea,
menopausal syndrome, puerperal infections and inflammations,
celulite, Herpes simplex and zoster, acne, eczema, Herpes sores,
skin virus, burn / wound healing, alopecia, psoriasis, dermatitis.
Simulation
According to Ostrom,3 simulation is a powerful alternative to
the other two symbol systems: verbal and mathematical reasoning.
Simulation has an advantage over the other two, which lies in high
portability on a computer, through a specific program or tool.
Using computer programs, quantitative or qualitative situations
can then be modelled and analysed. While there are many different
formal approaches to computer simulation, two of them seems par-
ticularly interesting for pharmacology, both of which lead to the
creation of a computer model of a complex system:4 i) Discrete
event, process simulation; through which models of known parts of
the systems are created and simulated. Its greatest advantage is that
it starts with a basic schema that is often derived from simple
observations of the real situation, which greatly facilitates the inte-
gration of an actual system into a process simulator. This approach
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is widely used and allows to analyse part of a set and to examine
its behaviour using a what-if analysis. This is why process simula-
tion is of great help in decision-making. Unfortunately, there is no
universal modelling language for process simulation, which often
requires deep translations to port models from one tool to another.
The second disadvantage is that to simulate a process with this
approach, it must be well known in all its parts; if part of the
process is uncertain, then it is impossible to validate a simulation
as a model of the real world to represent. Moreover, this method is
quite static, which means that the relationships between the differ-
ent parts involved in the model must be well described and that
there is no possibility of self-organization; ii) Agent-based simula-
tion; in pharmacoeconomics, it is often very difficult to describe in
detail the different parts and the whole.5 For this reason, discrete
event simulation of processes, at least alone, does not seem the
ideal tool to model these complex environments, where not only
costs are relevant, but also other outcomes, like non-monetary
indicators (e.g. life expectancy, life quality and so forth). On the
other hand, there are formalisms that make it possible to investi-
gate the state of emergency of social behaviour by creating and
exploring models. Thanks to the ever increasing computing power,
it is possible to create software based on intelligent agents whose
aggregated behaviour is often complex and difficult to predict and
which can be used in open and distributed systems. A software
agent can be described as a flexible system capable of dynamic and
autonomous actions to achieve its design objectives located in a
given environment. The main characteristics of a software agent
are: the ability to carry out actions according to a certain external
contribution, which in turn can change the environment itself;
autonomy in the execution of actions, without human intervention;
flexibility and adaptability. Some specific agents can also be
proactive, meaning they are targeted and social, as they can inter-
act with other artificial agents, robots and humans.
Data mining
Data mining6 is the key element of the Knowledge Discovery
in Databases (KDD) task. KDD is defined as the process of identi-
fying valid, novel, potentially useful and ultimately understandable
patterns in data. Finally, we could add that such a task typically
involves a large amount of data that is typically stored in analyti-
cally oriented data stores called data marts. Data mining is not a
field in itself; it is rather a collection of methods of data analysis
from various areas of computer science, artificial intelligence and
statistics. Statistics in particular provide mathematical concrete-
ness for many of the methods of date mining. Data mining was
born in the last decades to help users gain useful knowledge from
the otherwise overwhelming amount of data coming from both the
web and the data collected daily by companies. The type of knowl-
edge that users can gain from the raw data is heterogeneous and
depends above all on the type of data available.
The type of data and the type of task guide the data analysis
process itself, i.e. rather the production of an artigianalized process
guided by experience than the result of an automatic process. The
types of tasks that data mining could perform can be roughly divid-
ed into two categories.6,7 Forecasting and descriptive tasks. The
first type of tasks tries to discover a model that controls the behav-
iour of some variables in a system to predict such values in zones
not covered by the examples. The second type of task tries to find
some categorizations of the data that generate a shrunken descrip-
tor for wider data segments.
Predictive data mining
One of the predictive tasks of data mining is to find a form of
classification of the elements contained in the data mart from a set
of raw data. If there is a finite set of classes that describe the
domain of the data, classification can be performed by some if-
then rules that help the user to classify a new element in such a pre-
defined class.
Such a classification process is based on the values of some
characteristics of the item itself and can be deterministic (e.g. there
is no doubt that the item belongs to the given class) or heuristic
(e.g. the assignment of the item to one or more classes is given
with a certain degree of certainty). The association model extracted
so far can take the form of a decision tree instead of a set of if-then
rules, but the purpose of the model retrieved remains the same. If
the classification domain is not finite (for example, if the variable
interested in the prediction process is a real number), the operation
is called regression. The regression task helps the user to model an
analytical function that describes the data set passed to the task and
can predict new, un-transmitted values.
Descriptive data mining
Descriptive data mining is about discovering interesting regu-
larities in the data, uncovering patterns and finding interesting sub-
groups in the mass of data. This type of data mining leads to a cat-
egorization of the original amount of data that was not recogniza-
ble before the task was executed. The domain expert must then
interpret the patterns revealed so far to explain them. A typical
product of this type of task is the discovery of association rules that
find immature relationships between the values of characteristics
when looking at the examples proposed as training. Such associa-
tion rules can be used as classifiers to find some subgroups that
divide the population into relevant clusters. The clustering reflects
an important division in the data that could be decisive in using a
small number of stereotypes instead of a large number of single
points. Another important task in connection with data mining is
the use of advanced visualization techniques. Since data analysts
and domain specialists do most of the discovery work, it is very
important to find good visual metaphors to give users the right
intuition for analysis.
Of course, such metaphors are only useful to guide intuition, to
ensure mathematical soundness, data mining is supported by statis-
tical methods such as probability laws for the prediction of item val-
ues, Bayesian theorems for the definition of some kind of causality,
and so on. The techniques of data mining, which are based on statis-
tics, require a large number of elements in order to achieve satisfac-
tory results. If only a few examples are available, techniques of
machine learning from AI and inductive logic are proposed. Such
techniques are based on symbolic reasoning and non-classical logic
and do not require statistical tools to verify solidity.
Agent based process simulation fostered by data mining
In the field of pharmacoeconomics, the interactions among
basic subsystems are usually very complex, and could involve
human or non-deterministic participation. That would be very dif-
ficult, or even impossible to represent, with a straight discrete
process based simulation model; that is where agent-based connec-
tions between the subsystems can be used.4,5 These agents could
simulate the complex behaviour of systems where decisions take
place, with certain rules or through artificial intelligence patterns.
The agents5 should be quite simple, but structured, capable of act-
ing based on stimuli from the environment (i.e. the output of a sub-
system modelled with a process-based approach), and around an
output that influences the functioning of other subsystems.
Besides, certain phenomena (like diffusion, or emerging complex
behaviours) are definitely easier to simulate with an agent-based
approach. When the object of study is very complex, not all parts
are capable of being strictly deterministic, in the sense that they
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can be influenced by unforeseen influences from the environment.
With the help of a process-based approach it is possible to model
the deterministic, process based parts. By employing agent-based
rules, it would then be possible to create a more realistic model of
the complex system to be simulated.
The data for the simulation model built with this approach are
to be selected by data mining.6 In particular, not all data coming
from ozone-based treatments can be useful for the model. Whereas
in discrete event process simulation the emphasis is on the function-
al description of the modelled parts in detail, in agent-based simu-
lation the most important facet is the interaction among those parts.
As a matter of fact, it is interaction that produces a variety of behav-
iours that have could even not explicitly be described in the model
of the individual parts. In agent-based simulation, there are there-
fore two main areas levels that use different data, with different
goals. A micro level to describe a simple local behaviour and a
macro level, whose effects partly result from the micro level and
partly from the interaction of more elements. Such emerging behav-
iours could be revealed by non-explicit patterns in the simulation
data and a subsequent phase may be needed for simulation to reveal
the model that subdivides the data. Data mining techniques can
therefore be the key to unveiling non-trivial knowledge through the
initial assumption used to build the micro level, the model and
structure of the agent aggregation that emerged from the simulation.
Data mining and machine learning in general can be used in differ-
ent ways in agent-based simulation;6,7 it is possible to divide these
contributions into two main tasks: i) Ex ante, where machine learn-
ing and data mining techniques can be used to achieve the one kind
of intelligent behaviour that combines the data of past executions of
simulation learning from experience and tuning some initial param-
eters of the simulation to a local maximum; ii) Ex post, where final
results of a simulation are analysed using data mining techniques to
uncover interesting patterns in data, helping to better model the
behaviour of the overall systems. Note that the behaviour of the sys-
tem is usually more than the sum of the parts and is not described
in the first phase of the simulation task. Data mining could be used
to create a model that is supported by statistical evidence that could
be an initial hypothesis about the system.
Conclusions
This paper has a theoretical aim; its purpose is about introduc-
ing a hybrid simulation technique to be applied to the pharma-
coeconomic analysis of ozone therapy. In particular, the approach
of pharmacoeconomics is that of comparing the outcome of a tra-
ditional therapy with that of a different therapy. Ozone therapy is
very interesting for medicine, since the effects and actions of O3
are mainly positive and beneficial for many different diseases. This
makes ozone therapy as a very good candidate to be studied with
the approach of pharmacoeconomics. While costs (both direct,
indirect and intangible) are very important for deciding which ther-
apy should be favoured, also other factors have to be taken into
account like, for instance, lives saved, life years after therapy, qual-
ity of life and so on. This is why traditional approaches to pharma-
coeconomics could come short (e.g. statistics); that’s where simu-
lation could be an effective method for evaluating a broader range
of outcomes. For this reason, two simulation paradigms are dis-
cussed in this work, namely discrete event process simulation - to
simulate those parts of the process which are well known and eas-
ily mouldable as a flow of actions and if/then clauses – and agent
based simulation – to represent those parts or interactions where
only general rules are known and the emergent aggregate behav-
iour is not determined a priori but rather coming out from the
whole system and its ever-changing essence. So the combination
of these two approaches can be a powerful analytical method to be
applied to pharmacoeconomics in general and to ozone therapy in
particular, as a case study. Moreover, in order to select the data to
be used in such simulations, but also to analyse results coming
from them, a data mining approach is proposed.
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